New findings show a link between micronutrient supplementation and reduced risk of recurrence during tuberculosis chemotherapy, according to a study published in the June 1 issue of The Journal of
More: continued here
Papers presented at the 1st European Lung Cancer Conference, jointly organised by the European Society for Medical Oncology (ESMO) and the International Association for the Study of Lung Cancer (IASLC
More: continued here
By restoring two small molecules that are often lost in chronic leukemia, researchers were able to block tumor growth in an animal model.
More: continued here
Asbestos Disease Mesothelioma Consolidation Loan Refinance Student Maine Mesothelioma Lawyer Kentucky Mesothelioma Lawyer Alimta Mesothelioma Pemetrexed Treatment Asbestos Cancer Law Lawyer Mesothelioma Google Espn Nfl … …
More: continued here
New York Times Mesothelioma Facts Alimta Mesothelioma Pemetrexed Treatment Disney Vacation Club Student Loan Guaranteed Student Loans New Jersey Mesothelioma Lawyer Mesothelioma Attorney San Diego Google Car Tips.
More: continued here
Lung cancer is generally divided into two main categories; small cell and non small cell. The small cell lung cancer is further divided into several additional subcategories. The vast majority (approximately 80 percent) of people diagnosed with lung cancer have non small cell lung cancer.
More: continued here
A mesothelioma research group has discovered that treatment with anti-cancer drug Pemetrexed may be more effective if patients are treated with caffeine before receiving chemotherapy. Pemetrexed (sold under the brand name Alimta) is …
More: continued here
Asbestos fibers can cause a variety of dangerous diseases, including asbestosis, pleural plaques, lung cancer, and mesothelioma. Research shows that the ingestion or inhalation of these fibers causes damage to the lungs and the development of cancer over an extended period of time. When the human body inhales an irritating substance, the body normally produces mucus to surround the irritant.
More: continued here
Clinicians have achieved a gratifyingly high success rate in treating childhood leukemias—with up to 90 percent five-year survival for acute lymphoblastic leukemia and 60 percent for acute myelo
More: continued here
In February 2004, the Food and Drug Administration approved the chemotherapy drug Pemetrexed (which is marketed under the brand name Alimta) for the treatment of malignant pleural mesothelioma. Pemetrexed in combination with the …
More: continued here






